0
Startups & Venture·September 24, 2026·1 min read

Drug Benefits Firm Rightway Eyes Eventual IPO After New Funding

Share

A PBM like Rightway covering ~3M lives and talking IPO after new funding shows the wedge against legacy healthcare conglomerates is real. If you're a mid-market employer, the menu of unbundled, tech-forward benefits options is expanding — use that leverage in your next renewal cycle.

Startups & Venture

VFX company DNEG's AI unit Brahma, whose customers include Warner Bros. and the NBA, raised $150M led by Indian PE firm Multiples at a $2B post-money valuation

A $150M round at a $2B post-money for Brahma — with Warner Bros. and the NBA already on the roster — shows AI-native content pipelines are becoming their own category, not just tools inside legacy studios. If you produce or license media, assume turnaround time and revision cycles will compress sharply and renegotiate SLAs and pricing around throughput, not headcount.

CNBC
Startups & Venture

Sources: DeepSeek's annualized revenue run rate hits $1B, up from less than $500M a few months ago, as it aims to finalize a ~$7.5B fundraise by late October

A $1B run rate doubling in a few months while targeting a ~$7.5B raise says the LLM market is rewarding distribution and price aggression at scale, not just raw capability. If you’re building on third-party models, assume unit economics and vendor leverage can change fast as players with this growth profile push harder into enterprise and infra deals.